Abstract:The pathological presentation of Alzheimer disease (AD), the leading cause of senile dementia, involves regionalized neuronal death and an accumulation of intraneuronal and extracellular filaments termed neurofibrillary tangles and senile plaques, respectively. One of the β-amyloid peptides (Aβ), the Aβ1-42 form, is primarily responsible for neuronal damage and cell death that is the main component in the senile plaques. Over the past twenty years, the amyloid hypothesis has been strongly supported by a wealth of evidence, including data from genetic studies of Alzheimer disease. Amyloid cascade hypothesis states that the accumulation and deposition of fibrillar Aβ is the primary driver of neurodegeneration and cognitive decline leading to dementia. AD is a clinicopathological syndrome in which different gene defects can lead--directly or indirectly--to alter APP expression or proteolytic processing as such to change Aβ stability or aggregation. These result in a chronic imbalance between Aβ production and clearance. Gradual accumulation of aggregated Aβ initiates a complex, multistep cascade that includes gliosis, inflammatory changes, neuritic/synaptic change, tangles and transmitter loss. The evidence that links Aβ to the pathogenesis of AD is substantial, but the means by which these peptides exert their toxic effects, and where in neuronal cells they act, is far from clear. The up-to-date proceeding in the molecular mechanism of β-amyloid peptides is overviewed.

Amyloid-β and Tau in Alzheimer's Disease

Progress in molecular mechanisms of β-amyloid peptides in alzheimer's disease

Amyloid Beta and Tau: from Physiology to Pathology in Alzheimer’s Disease

Interaction between Aβ and Tau in the Pathogenesis of Alzheimer's Disease

Interaction Between A Beta And Tau In The Pathogenesis Of Alzheimer'S Disease

[Alzheimer's Disease: Advance in Researches on Beta-amyloid Protein].

Intracelluar Aβ accumulation in neurons and the pathogenesis of Alzheimer's disease

Advances in the β-amyloid precursor protein of Alzheimer's disease

Targeting Synaptic Pathology in Alzheimer’s Disease

Human beta-secretase and Alzheimer's disease

The Early Events That Initiate Β-Amyloid Aggregation in Alzheimer’s Disease

Tau Abnormalities and the Potential Therapy in Alzheimer’s Disease

Spreading of Pathology in Alzheimer's Disease

Amyloid-β Plaques Enhance Alzheimer's Brain Tau-Seeded Pathologies by Facilitating Neuritic Plaque Tau Aggregation

Progress in pathogenesis and treatment of Alzheimer's disease

The Role of MicroRNAs in Aβ Deposition and Tau Phosphorylation in Alzheimer’s Disease

Intracellular A beta and its Pathological Role in Alzheimer's Disease: Lessons from the Cellular to Animal Model

The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases

Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration

ChemInform Abstract: Tau Protein Associated Inhibitors in Alzheimer Disease

Tau Protein Associated Inhibitors in Alzheimer Disease